Share

Finding the best treatment for quitting smoking

accreditation
Quitting smoking from Shutterstock
Quitting smoking from Shutterstock


How quickly a smoker breaks down nicotine is a guide to which therapy is best for kicking the habit, according to new research.

Link between craving and enzyme

Most smokers who try to give up tobacco fail within the first week, so matching them to the best treatment is essential, its authors said.

Previous research has found a link between tobacco craving and levels of an enzyme called CYP2A6 which breaks down nicotine.

The faster the nicotine is metabolised, the likelier it is that the smoker will want to light up again soon, and the harder it will be to quit.

Read: Want to quit?

Scientists in the United States and Canada used a biomarker – the speed at which CYP2A6 does its job – to see whether nicotine patches or a non-nicotine replacement drug called hantix or Champix) were more effective.

Smokers who broke down nicotine quickly – most smokers, in fact – were twice as likely to quit if they used varenicline than if they used patches, they found.

They also had a better chance of staying off tobacco six months later.

Slower metabolisers found nicotine patches to be as effective as varenicline, but without that drug's side effects.

Electronic cigarettes a useful tool

The studies covered 1,246 smokers who wanted to quit, divided roughly equally into fast and slow metabolisers.

The smokers were randomly assigned to an 11-week course that comprised either a nicotine patch plus a dummy pill, varenicline plus a dummy patch or a dummy patch and a dummy pill.

The study did not cover electronic cigarettes, which some advocates say are a useful tool for giving up smoking.

Read: All about the e-cigarette

The results should lead to a simple blood test for nicotine metabolism so that doctors can better advise patients, the authors hope.

"As many as 65 percent of smokers who try to quit relapse within the first week," said Caryn Lerman, a professor of psychiatry at the University of Pennsylvania, who co-led the study.

"Matching a treatment based on the rate at which smokers metabolise nicotine could be a viable clinical strategy to help individual smokers choose the cessation method that will work best for them."

Around six million deaths annually can be attributed to tobacco, and smoking inflicts around $200 billion (169 billion euros) in health costs annually, the paper said.

The study appears in the journal The Lancet Respiratory Medicine.

Read more:
Quit smoking this year
Quit Day and beyond
Tips to help you finally quit smoking in 2015


Image: Quitting smoking from Shutterstock

We live in a world where facts and fiction get blurred
Who we choose to trust can have a profound impact on our lives. Join thousands of devoted South Africans who look to News24 to bring them news they can trust every day. As we celebrate 25 years, become a News24 subscriber as we strive to keep you informed, inspired and empowered.
Join News24 today
heading
description
username
Show Comments ()
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE